ArticleCureus2026
Outcomes of Percutaneous Cholecystostomy as a Bridging or Definitive Treatment for Acute Cholecystitis.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Percutaneous cholecystostomy (PC) is a minimally invasive intervention for managing acute cholecystitis in patients unfit for immediate cholecystectomy. Although it is widely used, its outcomes and factors influencing clinical success are not well understood. Objectives The goal of this study was to assess the outcomes of PC by examining various factors such as gender, type of cholecystitis, and procedure timing to correlate with symptom improvement, mortality, and the need for additional medical interventions. Materials and methods A cross-sectional study was conducted at The Royal Oldham Hospital UK, from December 2019 to June 2024. A total of 70 patients who underwent PC for acute cholecystitis were included. Data on patient demographics, type of cholecystitis, timing of the procedure, duration of catheter placement, and clinical outcomes were collected and analysed using appropriate statistical tests. Results Seventy patients (mean age 53.70±16.48 years; catheter duration 17.70±6.73 days) were analysed. Symptom resolution occurred in 61 (87.1%) patients and failed in nine (12.9%). Among middle-aged adults, 19 (90.4%) improved versus 42 (85.7%) older adults (p=0.766). In men, 36 (90.0%) cases were resolved, whereas 25 resolved in women (83.3%) (p=0.410). Bile leakage occurred in five (7.1%) patients, of which two (9.1%) were acalculous and three (6.3%) calculous (p=0.668). Mortality occurred in two patients (10.2%) in delayed PC and none (0.0%) in early PC (p=0.05). Additional interventions occurred in 32 (45.7%) patients: four (33.3%) short-term, nine (36%) moderate term and 19 (57.5%) long-term (p=0.945). PC led to high success (87.1%), low complications (7.1%), and low mortality (10.2%). Conclusion PC is an effective and safe way of managing acute cholecystitis in high-risk patients, with high symptom resolution and low complication rates. Our study findings did not reveal any significant effect of procedural and patient factors on outcomes. Appropriate patients and individually tailored management strategy is the key to advise best possible outcomes and long-term management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.